Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Cost of Goods Sold

Adverum Biotechnlgs Cost of Goods Sold Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Cost of Goods Sold from 2013 to 2020.
  • Adverum Biotechnlgs Cost of Goods Sold for the quarter ending June 06, 2020 was $19m a 48.15% increase of 9m year over year
  • Adverum Biotechnlgs Cost of Goods Sold for the last 12 months ending June 06, 2020 was $55m a 31.47% increase of 17m year over year
  • Adverum Biotechnlgs Annual Cost of Goods Sold for 2019 was $40m a -24.03% decrease of -10m from 2018
  • Adverum Biotechnlgs Annual Cost of Goods Sold for 2018 was $50m a 20.53% increase of 10m from 2017
  • Adverum Biotechnlgs Annual Cost of Goods Sold for 2017 was $40m a 24.02% increase of 10m from 2016
Other Income Statement Metrics:
  • Adverum Biotechnlgs EBITDA for the quarter ending December 12, 2018 was $-21m a 18.17% decrease of -4m year over year
  • Adverum Biotechnlgs Net Income for the quarter ending December 12, 2018 was $-16m a -9.84% increase of 2m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Cost of Goods Sold Data

06/2020$19m
03/2020$15m
12/2019$14m
09/2019$10m
06/2019$9m
03/2019$10m
12/2018$12m
09/2018$14m
06/2018$11m
03/2018$13m

Annual ADVM Cost of Goods Sold Data

2019$40m
2018$50m
2017$40m
2016$30m
2015$25m
2014$17m
2013$2m
2012$1m